Introduction:
The HESI Developmental and Reproductive Toxicology (DART) Technical Committee has formed a multidisciplinary team to investigate how nonclinical models can bridge data gaps in neonatal medicine development by identifying relevant animal models, providing knowledge of the pharmacodynamics during development and assessing long-term effects of acute and chronic treatment on development and outcome.

This survey will inform our first aim of identifying available nonclinical neonatal pediatric models that may inform the efficacy and long-term safety and tolerability of neonatal drug therapy, and provide the group with an overview of current nonclinical models available for neonatal diseases and treatments from across industry, regulatory agencies & academia.

Survey Instructions:
Many questions are open-ended, so please provide as much detail as possible in the open text areas. Please complete one form per model, and as much of this survey as possible!

The data of this survey will be used for scholarly purposes only (i.e., publication of the survey results in the peer-reviewed literature, presentation at scientific conferences, informing the larger Neonatal Pediatrics project.). You may request that the details of your model be excluded from publications and presentations in the survey below.

If you have questions regarding survey content, please contact:
Vijay Urmaliya (vurmaliya@its.jnj.com)
Susan Laffan (susan.b.laffan@gsk.com)
( Privacy & Cookie Notice

T